Citation Impact
Citing Papers
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol
2011 Standout
Switching to Reboxetine: An Efficacy and Safety Study in Patients With Major Depressive Disorder Unresponsive to Fluoxetine
2003
The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV-infected Patients
2007
Identification of Novel Toxicity-associated Metabolites by Metabolomics and Mass Isotopomer Analysis of Acetaminophen Metabolism in Wild-type and Cyp2e1-null Mice
2007
Venlafaxine Extended-Release
2001
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
No health without mental health
2007 Standout
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients<subtitle>A Randomized Trial</subtitle>
2009 Standout
Randomized trial comparing daily interruption of sedation and nursing-implemented sedation algorithm in medical intensive care unit patients
2008
Allosteric phenomena in cytochrome P450‐catalyzed monooxygenations
2001
Metabolic Drug Interactions Between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract
2011
Genetic modulation of the pharmacological treatment of pain
2009
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine
2003
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
Pharmacokinetics of selective serotonin reuptake inhibitors
2000
Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries
2009
CYP2E1 and oxidative liver injury by alcohol
2007
Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors
1997
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Pharmacology of antidepressants
2001
Drug development from marine natural products
2008 Standout
VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES
2004
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
2005
Sex bias in neuroscience and biomedical research
2010 Standout
The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
2013
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
2016
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
An Assessment of Drug-Drug Interactions: The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy Subjects
2008
Use of Psychotropic Medications Among HIV-Infected Patients in the United States
2003
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
The blood–brain barrier in neurodegenerative disease: a rhetorical perspective
2009
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
The Serotonin Syndrome
2005 Standout
The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity
2003
Multiple Novel Nonsynonymous CYP2B6 Gene Polymorphisms in Caucasians: Demonstration of Phenotypic Null Alleles
2004
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Role of the gut microbiota in nutrition and health
2018 Standout
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
2008 Standout
Acetaminophen‐induced acute liver failure
2005 Standout
Oxidative Stress in Cancer
2020 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
1998
Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans
2003
Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation
2003
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
A Natural CYP2B6 TATA Box Polymorphism (–82T→ C) Leading to Enhanced Transcription and Relocation of the Transcriptional Start Site
2005
Up‐regulation of P‐glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line
2008
Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors
1997
Enantiomers' potential in psychopharmacology—a critical analysis with special emphasis on the antidepressant escitalopram
2002
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
2017 Standout
REGULATION OF CYP2B6 IN PRIMARY HUMAN HEPATOCYTES BY PROTOTYPICAL INDUCERS
2004
Tenofovir-Associated Acute and Chronic Kidney Disease: A Case of Multiple Drug Interactions
2005
A Novel Distal Enhancer Module Regulated by Pregnane X Receptor/Constitutive Androstane Receptor Is Essential for the Maximal Induction of CYP2B6 Gene Expression
2003
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Methadone inhibits CYP2D6 and UGT2B7/2B4in vivo: a study using codeine in methadone‐ and buprenorphine‐maintained subjects
2011
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
AGA technical review on irritable bowel syndrome
2002 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Non-specific low back pain
2011 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Multicenter trial of low‐dose paclitaxel in patients with advanced AIDS‐related Kaposi sarcoma
2002
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
THE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION
2005
Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine
2004
Selective Induction of Human Hepatic Cytochromes P450 2B6 and 3A4 by Metamizole
2007
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Clinically Significant Drug Interactions with Newer Antidepressants
2011
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
2014
Gender differences in drug responses
2006
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Use of Robust Classification Techniques for the Prediction of Human Cytochrome P450 2D6 Inhibition
2003
In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction
2005
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
1998
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Review of sertraline and its clinical applications in psychiatric disorders
2001
Transport, metabolism and elimination mechanisms of anti-HIV agents
1999
Worldwide Variation in Human Drug-Metabolism Enzyme GenesCYP2B6andUGT2B7: Implications for HIV/AIDS Treatment
2012
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Competitive Inhibition of the Enzyme-Mimic Activity of Gd-Based Nanorods toward Highly Specific Colorimetric Sensing of l -Cysteine
2017
Pharmacokinetics/Pharmacodynamics of Acetaminophen Analgesia in Japanese Patients with Chronic Pain
2007
Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology
1998
Enzyme Promiscuity: A Mechanistic and Evolutionary Perspective
2010 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
A Quantitative Index of Substrate Promiscuity
2007
Metoprolol-paroxetine interaction in human liver microsomes: stereoselective aspects and prediction of the in vivo interaction.
2001
Chiral Diarylmethanes via Copper-Catalyzed Asymmetric Allylic Arylation with Organolithium Compounds
2015 StandoutNobel
Liposomal daunorubicin as treatment for Kaposi's sarcoma.
2007
ETCM: an encyclopaedia of traditional Chinese medicine
2018 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Coprescription of Tamoxifen and Medications That Inhibit CYP2D6
2010
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
PolymorphicCYP2B6: Molecular Mechanisms and Emerging Clinical Significance
2007
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Structure and Chemistry of Cytochrome P450
2005 Standout
The Structural Basis for Homotropic and Heterotropic Cooperativity of Midazolam Metabolism by Human Cytochrome P450 3A4
2011
Works of Su Duan being referenced
Human cytochromes mediating N -demethylation of fluoxetine in vitro
1997
Characterization of Six in vitro Reactions Mediated by Human Cytochrome P450: Application to the Testing of Cytochrome P450-Directed Antibodies
1996
Venlafaxine and metabolites are very weak inhibitors of human cytochrome P450-3A isoforms
1997
Appetite Suppressant Drugs as Inhibitors of Human Cytochromes P450
1998
Role of CYP3A and CYP2E1 in Alcohol-Mediated Increases in Acetaminophen Hepatotoxicity: Comparison of Wild-Type and Cyp2e1(–/–) Mice
2007
Stereoselective Conjugation of Oxazepam by Human UDP-Glucuronosyltransferases (UGTs): S-Oxazepam Is Glucuronidated by UGT2B15, While R-Oxazepam Is Glucuronidated by UGT2B7 and UGT1A9
2002
Midazolam Hydroxylation by Human Liver MicrosomesIn Vitro: Inhibition by Fluoxetine, Norfluoxetine, and by Azole Antifungal Agents
1996
Phenacetin O -deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine
1996
Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects
1999
Inhibition of triazolam clearance by macrolide antimicrobial agents: In vitro correlates and dynamic consequences*
1998
Inhibition of Human Cytochrome P450 Isoforms by Nonnucleoside Reverse Transcriptase Inhibitors
2001
ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO
2005
In Vitro Prediction of the Terfenadine‐Ketoconazole Pharmacokinetic Interaction
1994
EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
2003
Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir
1998
Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations
1999
Inhibition of Alprazolam and Desipramine Hydroxylation In Vitro by Paroxetine and Fluvoxamine
1995
Cytochrome P-450 2B6 Is Responsible for Interindividual Variability of Propofol Hydroxylation by Human Liver Microsomes
2001
Interindividual Variability in Acetaminophen Glucuronidation by Human Liver Microsomes: Identification of Relevant Acetaminophen UDP-Glucuronosyltransferase Isoforms
2001
Kinetic Characterization and Identification of the Enzymes Responsible for the Hepatic Biotransformation of Adinazolam andN-Desmethyladinazolam in Man
1998